临床试验Nct页
Clinical Trial Results:
A randomized, double-blind, parallel-group, placebo- and active calibrator-controlled study assessing the clinical benefit of SAR153191 subcutaneous (SC) on top of methotrexate (MTX) in patients with active rheumatoid arthritis (RA) who have failed previous tumor necrosis factor-alpha (TNF-α) antagonists.
| Summary | |
EudraCT number | 2010-021020-94 |
Trial protocol | DE IT HU CZ ES |
Global completion date | 15 Sep 2011 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 05 Oct 2016 |
First version publication date | 05 Oct 2016 |
Other versions | |
Summary report(s) | ACT11575 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.